Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

We aimed to evaluate the patient-reported outcomes (PROs) in a prospective phase III clinical trial, comparing neoadjuvant endocrine therapy (NET) with conventional neoadjuvant chemotherapy (NCT) in patients with hormone status positive, lymph node-positive premenopausal breast cancer (NCT01622361)....

Descripción completa

Detalles Bibliográficos
Autores principales: Gwark, Sungchan, Ahn, Sei Hyun, Noh, Woo Chul, Lee, Eun Sook, Jung, Yongsik, Kim, Lee Su, Han, Wonshik, Nam, Seok Jin, Gong, Gyungyub, Kim, Seon-Ok, Kim, Hee Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284076/
https://www.ncbi.nlm.nih.gov/pubmed/34277393
http://dx.doi.org/10.3389/fonc.2021.608207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284076/
https://www.ncbi.nlm.nih.gov/pubmed/34277393
http://dx.doi.org/10.3389/fonc.2021.608207

Ejemplares similares